THE STOP NULL MICE MODEL FOR SCHIZOPHRENIA DISPLAYS COGNITIVE AND SOCIAL DEFICITS PARTLY ALLEVIATED BY NEUROLEPTICS

被引:34
作者
Begou, M. [1 ,2 ]
Volle, J. [1 ,2 ]
Bertrand, J. -B. [1 ,2 ]
Brun, P. [1 ,2 ]
Job, D. [3 ]
Schweitzer, A. [3 ]
Saoud, M. [1 ,2 ]
D'Amato, T. [1 ,2 ]
Andrieux, A. [3 ]
Suaud-Chagny, M. -F. [1 ,2 ]
机构
[1] Inst Fed Neurosci Lyon, F-69677 Bron, France
[2] Univ Lyon 1, EA 4166, Ctr Hosp Vinatier, F-69677 Bron, France
[3] Univ Grenoble 1, Grp Physiopathol Cytosquelette, Inst Rech Technol Sci Vivant, CEA,Grenoble Inst Neurosci,Team 1,INSERM,U866, F-38042 Grenoble 9, France
关键词
schizophrenia; STOP null mice; cognitive defects; learning; memory; social interactions;
D O I
10.1016/j.neuroscience.2008.07.080
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recently evidence has accumulated that schizophrenia can arise from primary synaptic defects involving structural proteins particularly, microtubule associated proteins. Previous experiments have demonstrated that a STOP (stable tubule only peptide) gene deletion in mice leads to a phenotype mimicking some aspects of positive symptoms classically observed in schizophrenic patients. In the current study, we determined if STOP null mice demonstrate behavioral abnormalities related to the social and cognitive impairments of schizophrenia. Compared with wild-type mice, STOP null mice exhibited deficits in the non-aggressive component of social recognition, short term working memory and social and spatial learning. As described in humans, learning deficits in STOP null mice were poorly sensitive to long term treatment with typical neuroleptics. Since social and cognitive dysfunction have consistently been considered as central features of schizophrenia, we propose that STOP null mice may provide a useful model to understand the neurobiological correlates of social and cognitive defects in schizophrenia and to develop treatments that better target these symptoms. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 64 条
[1]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[2]   The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders [J].
Andrieux, A ;
Salin, PA ;
Vernet, M ;
Kujala, P ;
Baratier, J ;
Gory-Fauré, S ;
Bosc, C ;
Pointu, H ;
Proietto, D ;
Schweitzer, A ;
Denarier, E ;
Klumperman, J ;
Job, D .
GENES & DEVELOPMENT, 2002, 16 (18) :2350-2364
[3]   Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia [J].
Andrieux, Annie ;
Salin, Paul ;
Schweitzer, Annie ;
Begou, Melina ;
Pachoud, Bastien ;
Brun, Philippe ;
Gory-Faure, Sylvie ;
Kujala, Pekka ;
Suaud-Chagny, Marie-Francoise ;
Hoefle, Gerhard ;
Job, Didier .
BIOLOGICAL PSYCHIATRY, 2006, 60 (11) :1224-1230
[4]  
Bast T, 2007, REV NEUROSCIENCE, V18, P253
[5]   Haloperidol and clozapine affect social behaviour in rats postnatally lesioned in the ventral hippocampus [J].
Becker, A ;
Grecksch, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 76 (01) :1-8
[6]   Post-pubertal emergence of alterations in locomotor activity in STOP null mice [J].
Begou, Melina ;
Brun, Philippe ;
Bertrand, Jean-Baptiste ;
Job, Didier ;
Schweitzer, Annie ;
D'amato, Thierry ;
Saoud, Mohamed ;
Andrieux, Annie ;
Suaud-Chagny, Marie-Francoise .
SYNAPSE, 2007, 61 (09) :689-697
[7]   Motivation concepts in behavioral neuroscience [J].
Berridge, KC .
PHYSIOLOGY & BEHAVIOR, 2004, 81 (02) :179-209
[8]   Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs [J].
Black, MD ;
Simmonds, J ;
Senyah, Y ;
Wettstein, JG .
NEUROPHARMACOLOGY, 2002, 42 (03) :414-420
[9]   STOP proteins [J].
Bosc, C ;
Andrieux, A ;
Job, D .
BIOCHEMISTRY, 2003, 42 (42) :12125-12132
[10]   Cloning, expression, and properties of the microtubule-stabilizing protein STOP [J].
Bosc, C ;
Cronk, JD ;
Pirollet, F ;
Watterson, DM ;
Haiech, J ;
Job, D ;
Margolis, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2125-2130